AstraZeneca and Bristol Myers Squibb never held merger discussions and are not in talks now, a senior source close to the matter told Reuters on Wednesday. "There is no deal between AstraZeneca and BMS. There never was a deal to be done, and there are no discussions betwee
ETRACS 2xMonthly Pay Leveraged US Small Cap High Dividend ETN (SMHB) declares $0.0311/share monthly dividend. - Forward yield 9.15% - Payable Aug. 20; for shareholders of record Aug. 12; ex-div Aug. 12. - See SMHB Dividend Scorecard, Yield Chart, & Dividend Growth
ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B (HDLB) declares $0.2083/share monthly dividend. - Forward yield 14.11% - Payable Aug. 20; for shareholders of record Aug. 12; ex-div Aug. 12. - See HDLB Dividend Scorecard, Yield Chart, & Dividend Growth<
Bloomin' Brands raised its full-year earnings guidance Wednesday after higher menu prices pushed second-quarter profit above analyst expectations. The owner of Outback Steakhouse, Carrabba's Italian Grill, Bonefish Grill, and Fleming's Prime Steakhouse & Wine Bar reported
Investors react sharply as SpaceX projects $65 billion in capital expenditures for 2026, exceeding Wall Street estimates. SpaceX (SPCX) shares fell 11% to $111 in early trading Tuesday after the company outlined plans for $65 billion in capital expenditures in 2026. The pr
AMD (AMD) shares fell over 8% in premarket trading Wednesday despite reporting record revenue and profitability for the sector quarter, driven by strength in data centre revenue. For the quarter ended June 27, AMD reported adjusted EPS of $1.66 on revenue of $11.54B, up</p
FingerMotion (FNGR) appointed Jolie Kahn as chief executive officer, effective immediately, succeeding Martin Shen. - Martin Shen stepped down as CEO after leading the company from the OTC Markets to a Nasdaq listing. - Jolie Kahn most recently served as CEO of AVAX One... <p
Key Points - Q2 results exceeded guidance: Revenue rose 5% year over year to $46.9 million, subscription revenue increased 8% to $45.6 million, and adjusted EBITDA jumped 44% to $5.9 million. Non-GAAP gross margin reached a record 75%. - AI momentum accelerated: Kaltura si
Key Points - Lifecore reaffirmed its 2026 guidance for revenue of $120 million to $125 million and adjusted EBITDA of $20.5 million to $25 million, despite second-quarter revenue falling 6.2% year over year to $34.2 million and the net loss widening to $6.2 million. -... n
Key Points - Geron reported strong second-quarter performance, with revenue rising 17% year over year to $57.5 million and first-half revenue up approximately 24%. The company ended the quarter with $327 million in cash, equivalents, restricted cash and marketable securiti
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.